Advanced search
Publication Cover
Infection and Drug Resistance Volume 11, 2018 - Issue
Submit an article Journal homepage
42
Views
0
CrossRef citations to date
0
Altmetric
Short Report

Mutation EthAW21R confers co-resistance to protionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv

Julius Mugweru1 State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China;3 Department of Biological Sciences, University of Embu, Embu, Kenya
,
Jianxiong Liu4 State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou
,
Gaelle Makafe1 State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China;2 University of Chinese Academy of Sciences, Beijing, China
,
Gift Chiwala1 State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China;2 University of Chinese Academy of Sciences, Beijing, China
,
Bangxing Wang1 State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China
,
Changwei Wang1 State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China
,
Xinjie Li4 State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou
,
Yaoju Tan4 State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou
,
Wing Wai Yew5 Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China
,
Shouyong Tan4 State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, GuangzhouCorrespondence[email protected]
&
Tianyu Zhang1 State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China;2 University of Chinese Academy of Sciences, Beijing, ChinaCorrespondence[email protected]
 show all
Pages 891-894 | Published online: 13 Jun 2018

References

  • Wang F, Langley R, Gulten G, et al. Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med. 2007;204(1):73–78.
  • Thee S, Garcia-Prats A, Donald P, Hesseling A, Schaaf H. A review of the use of ethionamide and prothionamide in childhood tuberculosis. Tuberculosis. 2016;97:126–136.
  • Di Perri G, Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemother. 2004;54(3):593–602.
  • Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr. 1989;115(3):483–486.
  • Scardigli A, Caminero JA, Sotgiu G, Centis R, Ambrosio L, Migliori GB. Efficacy and tolerability of ethionamide versus prothionamide: a systematic review. Eur Respir J. 2016;48(3):946.
  • Jenner P, Ellard G, Gruer P, Aber V. A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man. J Antimicrob Chemother. 1984;13(3):267–277.
  • Winder FG. Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. Biol Mycobact. 1982;1:353–438.
  • Fattorini L, Iona E, Ricci ML, et al. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb Drug Resist. 1999;5(4):265–270.
  • DeBarber AE, Mdluli K, Bosman M, Bekker L-G, Barry CE. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2000;97(17):9677–9682.
  • Hanoulle X, Wieruszeski J-M, Rousselot-Pailley P, et al. Selective intracellular accumulation of the major metabolite issued from the activation of the prodrug ethionamide in mycobacteria. J Antimicrob Chemother. 2006;58(4):768–772.
  • Vilchèze C, Jacobs WR Jr. Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities. Microbiol Spectr. 2014;2(4):MGM2-0014-2013.
  • Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994;263(5144):227–229.
  • Vilchèze C, Weisbrod TR, Chen B, et al. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother. 2005;49(2):708–720.
  • Liu T, Wang B, Guo J, et al. Role of folP1 and folP2 genes in the action of sulfamethoxazole and trimethoprim against mycobacteria. J Microbiol Biotechnol. 2015;25(9):1559–1567.
  • Yang F, Njire MM, Liu J, et al. Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step. PLoS One. 2015;10(3):e0119341.
  • Zhang T, Bishai WR, Grosset JH, Nuermberger EL. Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains. Antimicrob Agents Chemother. 2010;54(7):2806–2813.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.